By studying Chikungunya virus, scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease.

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

Of the RSV patients aged 60 or older, 23.0% were admitted to an ICU, 31.5% had acute organ failure, and 9.8% received IMV or ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that ...

Frequent blood donors may be getting more than a warm, fuzzy feeling from their altruism, as giving blood may also enhance your ability to produce healthy blood cells, potentially reducing the ...

But they are the inspiration for a new approach to treating cancer that uses engineered fat cells to deprive tumors of nutrition. Researchers at UC San Francisco used the gene editing technology ...

Many cells make heat-shock proteins when they get ... the human respiratory syncytial virus. In 2023, when Brangwynne and Hyman were awarded the $3-million Breakthrough Prize for their work ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants, making maternal vaccination critical for newborn protection Vaccinating at 32 weeks of pregnancy optimizes ...

Respiratory syncytial virus (RSV) is the second most common pathogen ... BARS13 is based on the RSV G-protein with cyclosporine A adjuvant to induce regulatory T cells. BARS13 was safe in a phase 1 ...

An RSV vaccine is a shot that protects you from respiratory syncytial virus (RSV), which ... the gene for protein F is added to cells. As the cell grows, so does the protein.

The virus, which is the most common cause of lower respiratory tract infections, can infect nerve cells and trigger inflammation. A recent study has revealed why respiratory syncytial virus (RSV ...